123 related articles for article (PubMed ID: 34582886)
1. Longitudinal Outcomes from Conservative Management of Cervical Cancer Associated Ureteral Obstruction.
Botkin HE; Faidley KN; Loeffler BT; Mott SL; Hill EK; Erickson BA
Urology; 2021 Dec; 158():208-214. PubMed ID: 34582886
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management.
Faidley KN; Botkin HE; Loeffler BT; Mott SL; Hansen SC; Hill EK; Erickson BA
Urology; 2024 Apr; 186():101-106. PubMed ID: 38350551
[TBL] [Abstract][Full Text] [Related]
3. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
4. Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents.
Rotariu P; Yohannes P; Alexianu M; Rosner D; Lee BR; Lucan M; Smith AD
J Endourol; 2001 Dec; 15(10):979-83. PubMed ID: 11789979
[TBL] [Abstract][Full Text] [Related]
5. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up in conservative management of unilateral ureteropelvic junction obstruction with poor drainage and good renal function.
Arena S; Chimenz R; Antonelli E; Peri FM; Romeo P; Impellizzeri P; Romeo C
Eur J Pediatr; 2018 Dec; 177(12):1761-1765. PubMed ID: 30209594
[TBL] [Abstract][Full Text] [Related]
7. Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction.
Karnak I; Woo LL; Shah SN; Sirajuddin A; Ross JH
Pediatr Surg Int; 2009 Jan; 25(1):61-7. PubMed ID: 19043723
[TBL] [Abstract][Full Text] [Related]
8. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
Chao KS; Leung WM; Grigsby PW; Mutch DG; Herzog T; Perez CA
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1095-100. PubMed ID: 9539564
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
10. [Ureteral obstruction and hydronephrosis. A complication after aortic bypass surgery].
Andersen E; Fossdal JE; Skjeggestad O
Tidsskr Nor Laegeforen; 1994 Nov; 114(27):3188-90. PubMed ID: 7809871
[TBL] [Abstract][Full Text] [Related]
11. Bilateral hydronephrosis and acute kidney injury secondary to pelvis lipomatosis.
Baas W; O'Connor B; El-Zawahry A
Can J Urol; 2018 Feb; 25(1):9217-9219. PubMed ID: 29524979
[TBL] [Abstract][Full Text] [Related]
12. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
13. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.
Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P
J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery embolization for ureteric obstruction secondary to fibroids.
Mirsadraee S; Tuite D; Nicholson A
Cardiovasc Intervent Radiol; 2008; 31(6):1094-9. PubMed ID: 18574626
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction.
Song SH; Pak S; Jeong IG; Kim KS; Park HK; Kim CS; Ahn H; Hong B
Int Urol Nephrol; 2015 Jan; 47(1):19-24. PubMed ID: 25315466
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
17. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
18. Parenchyma-to-hydronephrosis Area Ratio Is a Promising Outcome Measure to Quantify Upper Tract Changes in Infants With High-grade Prenatal Hydronephrosis.
Rickard M; Lorenzo AJ; Braga LH; Munoz C
Urology; 2017 Jun; 104():166-171. PubMed ID: 28111223
[TBL] [Abstract][Full Text] [Related]
19. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
20. [Replacement of the ureter by using a scurasil prosthesis].
Zuluaga Gómez A; Espuela Orgáz R; Torres Ramírez C; Martínez Torres JL; Passas Martínez J; de la Fuente Serrano A
Actas Urol Esp; 1980; 4(4):183-8. PubMed ID: 7405642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
